Clinical Trial Update: Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating simvastatin as an add-on therapy to Copaxone (glatiramer acetate) for relapsing-remitting multiple sclerosis has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Anna Tsakiri | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: WITHDRAWN